- Home
- UGI vs MEDP Comparison
UGI vs MEDP Comparison
Compare UGI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGI
- MEDP
- Stock Information
- Founded
- UGI 1940
- MEDP 1992
- Country
- UGI United States
- MEDP United States
- Employees
- UGI N/A
- MEDP N/A
- Industry
- UGI Natural Gas Distribution
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- UGI Utilities
- MEDP Health Care
- Exchange
- UGI Nasdaq
- MEDP Nasdaq
- Market Cap
- UGI 7.7B
- MEDP 8.5B
- IPO Year
- UGI N/A
- MEDP 2016
- Fundamental
- Price
- UGI $36.29
- MEDP $309.36
- Analyst Decision
- UGI Buy
- MEDP Hold
- Analyst Count
- UGI 3
- MEDP 10
- Target Price
- UGI $31.33
- MEDP $343.22
- AVG Volume (30 Days)
- UGI 1.6M
- MEDP 344.5K
- Earning Date
- UGI 08-06-2025
- MEDP 07-21-2025
- Dividend Yield
- UGI 4.14%
- MEDP N/A
- EPS Growth
- UGI N/A
- MEDP 33.36
- EPS
- UGI 2.46
- MEDP 13.09
- Revenue
- UGI $7,318,000,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- UGI $6.56
- MEDP $5.64
- Revenue Next Year
- UGI $8.97
- MEDP $3.32
- P/E Ratio
- UGI $14.70
- MEDP $23.59
- Revenue Growth
- UGI N/A
- MEDP 9.87
- 52 Week Low
- UGI $22.01
- MEDP $250.05
- 52 Week High
- UGI $36.62
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- UGI 59.33
- MEDP 55.79
- Support Level
- UGI $35.47
- MEDP $294.07
- Resistance Level
- UGI $36.62
- MEDP $304.69
- Average True Range (ATR)
- UGI 0.57
- MEDP 9.68
- MACD
- UGI -0.06
- MEDP 0.72
- Stochastic Oscillator
- UGI 76.09
- MEDP 66.62
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.